Success Metrics

Clinical Success Rate
87.8%

Based on 65 completed trials

Completion Rate
88%(65/74)
Active Trials
14(14%)
Results Posted
45%(29 trials)
Terminated
9(9%)

Phase Distribution

Ph phase_4
16
16%
Ph phase_2
25
25%
Ph phase_3
26
26%
Ph not_applicable
16
16%
Ph phase_1
18
18%

Phase Distribution

18

Early Stage

25

Mid Stage

42

Late Stage

Phase Distribution101 total trials
Phase 1Safety & dosage
18(17.8%)
Phase 2Efficacy & side effects
25(24.8%)
Phase 3Large-scale testing
26(25.7%)
Phase 4Post-market surveillance
16(15.8%)
N/ANon-phased studies
16(15.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

65 of 75 finished

Non-Completion Rate

13.3%

10 ended early

Currently Active

14

trials recruiting

Total Trials

101

all time

Status Distribution
Active(17)
Completed(65)
Terminated(10)
Other(9)

Detailed Status

Completed65
unknown9
Recruiting9
Terminated9
Active, not recruiting5
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
101
Active
14
Success Rate
87.8%
Most Advanced
Phase 4

Trials by Phase

Phase 118 (17.8%)
Phase 225 (24.8%)
Phase 326 (25.7%)
Phase 416 (15.8%)
N/A16 (15.8%)

Trials by Status

unknown99%
completed6564%
not_yet_recruiting33%
withdrawn11%
active_not_recruiting55%
recruiting99%
terminated99%

Recent Activity

Clinical Trials (101)

Showing 20 of 101 trialsScroll for more
NCT06874452Phase 4

An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction

Recruiting
NCT06826417Not Applicable

Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety

Recruiting
NCT07254728Phase 1

A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

Completed
NCT07489885Phase 2

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Not Yet Recruiting
NCT07487831Phase 4

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Not Yet Recruiting
NCT07447063Phase 4

The Impact of Dietary Salt on the Severity of Eczema

Not Yet Recruiting
NCT07204314Phase 3

A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder

Recruiting
NCT05186753Phase 2

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Active Not Recruiting
NCT06795776Phase 3

Eschscholzia Study

Completed
NCT07413666Phase 1

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Recruiting
NCT04705220Not Applicable

Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome

Completed
NCT05776459Phase 2

Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

Active Not Recruiting
NCT07022938Phase 4

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

Completed
NCT07082829Phase 1

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Recruiting
NCT04624659Phase 3

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

Active Not Recruiting
NCT07239973Phase 1

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

Recruiting
NCT05212168Phase 1

Norovirus Challenge Study

Completed
NCT03497975Phase 2

PRISM Study-Pruritus Relief Through Itch Scratch Modulation

Completed
NCT06863194Phase 1

Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial

Recruiting
NCT05624138Phase 3

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
101